DBCO-PEG-LA (MW 400)
DBCO-PEG-LA (MW 400) is a PEG derivative consisting of DBCO, PEG units, and Lipoic Acid. DBCO-PEG-LA (MW 400) contains a DBCO group and can undergo a strain-promoted alkyne-azide cycloaddition reaction (SPAAC) with molecules containing an azide group[1].
Product Specifications
UNSPSC
12352200
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Smiles
O=C(CCCCC(NCCOCCNC(CCCCC1CCSS1)=O)=O)N2C3=C(C=CC=C3)C#CC4=CC=CC=C4C2.[n]
Molecular Weight
400 (Average)
References & Citations
[1]Yamazaki S, et al. Antibody Modification via Lipoic Acid Ligase A-Mediated Site-Specific Labeling. Chem Biodivers. 2025 Mar;22 (3) :e202402113.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940178-100 1x 100 µL
CD50 (ICAM-3) (186-2G9), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741429-100 1x 100 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400178-100 1x 100 µL
CD50 (ICAM-3) (186-2G9), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680012-500 1x 500 µL
Tyrosinase (T311), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742391-100 1x 100 µL
GAD1 / GAD67 (GABAergic Neuronal Marker) (GAD1/2391), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details